a developer of pharmaceutical products for the treatment of cancers
Industry Biotechnology
A.I.dvisor indicates that over the last year, ONCY has been loosely correlated with NTLA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCY jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To ONCY | 1D Price Change % | ||
---|---|---|---|---|
ONCY | 100% | -0.92% | ||
NTLA - ONCY | 34% Loosely correlated | -3.65% | ||
CDMO - ONCY | 33% Poorly correlated | -7.69% | ||
RIGL - ONCY | 33% Poorly correlated | -2.38% | ||
INZY - ONCY | 33% Poorly correlated | -5.60% | ||
RCUS - ONCY | 32% Poorly correlated | -3.21% | ||
More |
Ticker / NAME | Correlation To ONCY | 1D Price Change % |
---|---|---|
ONCY | 100% | -0.92% |
cancer theme (87 stocks) | 29% Poorly correlated | +0.89% |
biotechnology theme (248 stocks) | 27% Poorly correlated | +5.56% |
drugs theme (265 stocks) | 26% Poorly correlated | +5.37% |
treatment theme (61 stocks) | 26% Poorly correlated | +0.91% |
pharmaceuticals theme (167 stocks) | 24% Poorly correlated | +0.82% |
More |